Following the recent outbreak of monkeypox in Nigeria, the United States Embassy has reacted,
The embassy stated that the outbreak of monkeypox in Nigeria has no link to the North American country.
The statement was released as a reaction to claims that the U.S. government was using some laboratories under its control to spread monkeypox disease in Nigeria.
Click The Image To Know More About ELEOS SPECIALIST HOSPITAL👇
The embassy speaking through an Information Specialist at the Public Affairs Section of the U.S. Consulate General, Temitayo Famutimi, said the U.S. government has continued to support Nigerian health authorities with technical assistance and funding to tackle disease outbreaks such as COIVD-19 and monkeypox, among others.
He added that sponsors of such claims have also called on the World Health Organisation (WHO) to investigate these laboratories.
The statement read;
U.S.-Nigeria Collaboration on Infectious Disease Threats
Recent misleading posts on social media wrongly speculate on the origin of the current global outbreak of monkeypox disease, and supposedly call for WHO to investigate so-called “U.S.-controlled laboratories” in Nigeria.
Such reports are pure fabrication. There is zero merits to any allegations regarding the use of U.S.-assisted Nigerian laboratories in the spread of monkeypox. Furthermore, there are no “U.S.-controlled” laboratories in Nigeria.
These falsehoods detract from the work that the United States, in close coordination with Nigerian and multilateral partners, accomplished together on public health, including disease surveillance, diagnosis, prevention, and control.
The collaborative work between Nigeria and the United States has provided opportunities for technical assistance in capacity building, equipment, commodities/consumables, and funding to critical public health programmes, hospitals, and laboratories. All of this contributes greatly to the prevention and amelioration of global disease outbreaks.
Monkeypox is not a new disease, nor is it unique to Nigeria or this region, having first been diagnosed in 1970 in the DRC. As we work together to contain its spread, exported cases have been reported in the United Kingdom, United States, and other parts of the world.
The United States government continues to lend its support and work closely with the government of Nigeria in responding to the outbreak.
Through our collaborative interventions, U.S. government agencies working in Nigeria (including the U.S. Centers for Disease Control and Prevention (CDC), United States Agency for International Development (USAID), and the Walter Reed Army Institute of Research Program) and their implementing partners have supported both national and state laboratories with technical assistance and funding.
These laboratories are Nigerian, and U.S. support enables them to provide essential services for the public good and the health of Nigeria’s citizens.
Especially important, our support to laboratories across the country extends to quality improvements that ensure they have appropriate levels of biosafety and biosecurity requirements in place.
We will continue to collaborate with the Nigerian government on the ongoing global monkeypox and COVID-19 outbreaks and intensify support to Nigeria in other areas on which we have proudly partnered over the years, such as HIV epidemic control, tuberculosis eradication, malaria elimination, prevention of vaccine-preventable disease, and enhancing food and nutrition.
